Read articles from Global
September 01, 2026 by substack.com
Lost in the cloud: How vaping was undermined by a moral panic
Vaping was not undermined by evidence alone, but by the story built around it. Moral panic, media pressure and political caution turned a lower-risk alternative for smokers into a cultural threat that became easier to condemn than to understand. That distortion matters because fear can stop people from recognising the difference between smoke and vapour. Public health should resist panic long enough to keep the risk hierarchy clear.
September 01, 2026 by substack.com
The Human at the Terminal: A Demonstration in Real Time
AI can produce fluent answers, but fluency is not the same as judgement. The stronger work begins where a human challenges the easy phrasing, demands better distinctions and refuses to let public-health clichés stand in for evidence. In nicotine debates, that means separating dependence, addiction, delivery systems and combustion with far more care. The human at the terminal still matters because precision is not automatic — it has to be insisted upon.
September 01, 2026 by protectingtaxpayers.org
Summer Reading: Tobacco Harm Reduction
A summer reading list on tobacco harm reduction is a reminder that this debate is built from evidence across policy, behaviour, economics and lived experience. The case for safer nicotine alternatives does not rest on one study or one country; it grows from a wider pattern showing that smokers need practical routes away from combustion. Reading across that evidence matters because prohibition, misinformation and one-size-fits-all regulation keep returning in different forms. Better tobacco policy starts with understanding the full picture, not only the arguments that fit existing assumptions.
August 31, 2026 by substack.com
Four Countries, Four Nicotine Futures
Four countries can tell four very different nicotine stories. Some make safer alternatives visible and accessible; others restrict them while cigarettes remain easy to buy; some lose control to illicit markets; others show how smoking can fall faster with a broader harm reduction approach. These are not abstract policy experiments — they shape what real smokers can actually do. The future of nicotine policy will depend on whether governments learn from outcomes or keep defending assumptions.
August 31, 2026 by substack.com
In defense of nicotine
Nicotine is usually discussed only as a problem, which leaves the public with a distorted picture of why people use it. Its potential upsides do not make it harmless or suitable for everyone, but they do help explain demand beyond addiction alone. The main public health failure comes from confusing nicotine with smoking. A more honest debate would separate the substance from combustion, acknowledge both risks and benefits, and focus policy on reducing the harms that actually kill.
August 27, 2026 by clearingtheair.eu
Op-Ed: Harry Shapiro – Global State of Tobacco Harm Reduction
The new Global State of Tobacco Harm Reduction report points to a movement that continues despite resistance, denial and political discomfort. Around the world, people are moving away from cigarettes through safer nicotine products, even where policy has been slow to recognise the shift. That progress should not be ignored because it challenges older tobacco-control assumptions. Harm reduction is no longer a marginal idea; it is part of the real-world response to smoking.
August 26, 2026 by gfn.tv
Does Prohibition Actually Protect Public Health? | GFN Voices 2026 #5
Prohibition often gives the appearance of protection while moving risk somewhere harder to see. Demand for nicotine does not disappear because legal access is restricted; it shifts towards illicit supply, weaker safeguards and fewer opportunities to guide smokers away from cigarettes. Public health should be judged by outcomes, not by how strict a policy sounds. A more effective approach would reduce harm through regulation, enforcement and realistic access to safer alternatives.
August 26, 2026 by washingtonexaminer.com
Anti-vaping hysteria keeps smokers hooked. Trump’s FDA is (finally) embracing reality
FDA authorisation of lower-risk nicotine products matters because it gives smokers something more useful than fear. A credible harm reduction framework should recognise products that can reduce exposure to combustion while maintaining strong standards for evidence, marketing and youth protection. The aim is not to normalise nicotine use, but to make the path away from cigarettes more realistic for adults who still smoke. Regulation should reward products that can help reduce harm, not keep the most dangerous option as the easiest one to find.
August 26, 2026 by bbc.com
Nicotine vapes best chance to quit smoking, major review finds
Nicotine vapes being described as one of the best chances to quit smoking should shift the tone of the debate. Adult smokers need clear advice about options that can move them away from combustible tobacco, not messaging that makes every nicotine product sound equally dangerous. Vaping is not risk-free, but its value lies in comparison with continued smoking. Public health communication should make that hierarchy understandable enough for people to use it.
August 21, 2026 by gfn.tv
GFN.TV Interviews #94 | CAUTIOUS SHIFT | NHRC Pushes the Conversation on Safer Nicotine
A cautious shift in the nicotine debate still matters. Moving the conversation towards safer nicotine products creates space for evidence, consumer experience and the reality that many adults continue to smoke despite repeated quit attempts. Progress does not require abandoning caution; it requires applying it proportionately. The strongest public health position is one that reduces smoking-related harm while keeping regulation honest about differences in risk.
- Page 1 of 165